Synergy CHC Corp.

What they do

Synergy CHC Corp. develops and sells consumer health, beauty, and lifestyle products through two marquee brands: FOCUSfactor, a brain health supplement with over 34 SKUs, and Flat Tummy, a wellness brand with 13 SKUs. Products are sold primarily through U.S. retailers including Costco, Amazon.com, Walmart, Walgreens, BJ's, and The Vitamin Shoppe. The company also sells direct to consumer through its website and has expanded into Canada and Mexico. Its asset-light model relies on third-party manufacturers.

Revenue drivers

• FOCUSfactor supplements — Brain health supplement line with over 34 SKUs, sold through major U.S. retailers and direct online. This is the flagship brand and a core revenue contributor.
• Flat Tummy — Nutritional products for weight management, with 13 SKUs. Online sales were negatively impacted by out-of-stock issues for key items in Q1 2026.
• Functional beverages (FOCUSfactor energy RTD) — A newer product line with focus plus energy ready-to-drink beverages. Generated over $650,000 in Q1 2026, exceeding total beverage revenue for all of 2025.
• License revenue — Non-recurring license revenue of $1.5 million was recognized in Q1 2025 but did not repeat in Q1 2026, causing a year-over-year revenue decline.

Recent performance

For Q1 2026, revenue was $5.49 million, down from $8.17 million in Q1 2025, due to the absence of $1.5 million in license revenue and Flat Tummy online out-of-stocks, partially offset by strong beverage growth. Gross margin was 72.3% versus 75.4% (or 70.0% normalized, excluding license revenue). Net loss was $2.57 million versus net income of $0.88 million; EPS was -$0.23 versus $0.10. Cash used in operating activities was $2.0 million in Q1 2026. Cash balance was $0.30 million as of March 31, 2026, with a working capital deficit of $0.50 million.

Strategy

The company intends to accelerate growth of FOCUSfactor supplements and FOCUSfactor energy RTD products, leveraging its asset-light model and third-party manufacturing. It is expanding distribution in the U.S. and internationally (Canada since 2020, Mexico since 2025). Management is focused on growing its two verticals—nutraceuticals and ready-to-drink beverages—to create a balanced portfolio. The company is also trying to manage its high leverage, as its capital structure has been highly levered since 2015 acquisitions.

Risks

• High leverage and liquidity risk — Total liabilities of $31.9 million exceed total assets of $6.5 million, with $25.0 million in long-term debt and a working capital deficit, raising going-concern risk.
• Revenue decline and reliance on key customers — Revenue fell from $34.8M in 2024 to $30.4M in 2025 and continued to decline in Q1 2026; a loss of a major retailer like Costco or Walmart could materially hurt results.
• Product competition and substitution — The nutritional supplements and functional beverage markets are highly competitive with few barriers to entry, and larger competitors may capture market share.
• Supply chain and manufacturing dependence — The asset-light model relies on third-party manufacturers; any failure to supply products in sufficient quantities or on time could disrupt sales.

Outlook

Management expects 2026 to be a year of sustainable growth, citing momentum in the functional beverage business, which is operating at an estimated annual run rate exceeding $4 million. They expect continued expansion of distribution footprint and reorder activity to drive growth. No specific revenue or profitability guidance was provided.